{"slideshow_credits": null, "snippet": "The Generic Pharmaceutical Association defends settlements of patent litigation.", "abstract": "Letter from Ralph G Neas, president and chief executive,Generic Pharmaceutical Assn, comments on July 27 article on ruling that found pharmaceutical companies were engaging in anticompetitive behavior.", "section_name": "Opinion", "print_page": "20", "document_type": "article", "byline": [], "web_url": "http://www.nytimes.com/2012/08/03/opinion/drug-settlements.html", "lead_paragraph": "The Generic Pharmaceutical Association defends settlements of patent litigation.", "headline": {"main": "Drug Settlements", "print_headline": "Drug Settlements", "content_kicker": "Letter", "kicker": "Letter"}, "_id": "53f9718738f0d84410bcafb0", "word_count": "190", "multimedia": [], "pub_date": "2012-08-03T00:00:00Z", "source": "The New York Times", "news_desk": "Letters", "keywords": [{"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "Y", "rank": "1"}, {"value": "Inventions and Patents", "name": "subject", "is_major": "N", "rank": "2"}, {"value": "Suits and Litigation", "name": "subject", "is_major": "N", "rank": "3"}, {"value": "Generic Brands and Products", "name": "subject", "is_major": "Y", "rank": "4"}, {"value": "Medicine and Health", "name": "subject", "is_major": "N", "rank": "5"}, {"value": "Federal Trade Commission", "name": "organizations", "is_major": "N", "rank": "6"}, {"value": "Antitrust Laws and Competition Issues", "name": "subject", "is_major": "Y", "rank": "7"}], "blog": [], "subsection_name": null, "type_of_material": "Letter"}